Study at a glance
How does a vitamin D deficiency cut-off differ from a target?
This review separates a vitamin D deficiency cut-off from a desired blood-level target. A cut-off identifies a level below which risk becomes a concern for a particular purpose. A target asks whether aiming for a higher level provides extra benefit. The usual measurement is 25-hydroxyvitamin D in blood.
Does research show one ideal vitamin D blood level?
Studies of parathyroid hormone, involved in calcium regulation, have not identified one universal higher target. This hormone is also affected by age, kidney function, calcium intake and other factors. In a trial of women after menopause with low vitamin D levels, supplements substantially raised blood levels. Calcium absorption changed only modestly, without a clear boundary supporting one higher target for everyone.
What did the 2024 vitamin D guideline conclude?
The Endocrine Society reviewed trials in generally healthy populations. It could not identify blood-level cut-offs that reliably predicted specific benefits from supplements. The Society therefore stopped endorsing its previous universal target for those populations.
Does a level that prevents deficiency give everyone the most benefit?
A level intended to cover nearly everyone’s nutritional needs is not automatically the ideal level for every individual. Severe deficiency can be harmful, but this alone does not prove that aiming higher gives extra benefit. Higher targets may be appropriate in some settings, but they need their own supporting evidence. The purpose of the number matters.
Read the full article below ↓A vitamin D deficiency threshold and a functional target range answer different questions. A deficiency threshold identifies a concentration below which the risk of inadequate vitamin D-dependent physiology becomes sufficiently important for a defined clinical or public-health purpose. A functional target asks whether deliberately maintaining 25-hydroxyvitamin D [25(OH)D] at a higher concentration produces additional physiological or clinical benefit. This distinction develops the framework in Vitamin D Thresholds vs Targets. For the complete evidence treatment, see Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Full Study.
A threshold does not automatically define an optimum
Vitamin D status exists on a physiological continuum. As 25(OH)D falls, calcium absorption, PTH secretion, bone turnover and other compensatory processes may progressively change. A deficiency threshold therefore represents an evidence-based boundary of concern rather than a biological switch that every person crosses at exactly the same concentration.
The Institute of Medicine model illustrates this distinction. Its dietary reference framework concluded that approximately 20 ng/mL (50 nmol/L) would meet the vitamin D requirements of at least 97.5% of the population for the skeletal outcomes used in the model. That did not mean that 20 ng/mL was declared the universal optimum for every individual or every biological function.
This is why the numerical categories described in Vitamin D Deficiency Definitions must be interpreted according to their purpose rather than treated as interchangeable targets.
Physiological markers do not provide one universal higher target
PTH is inversely associated with 25(OH)D and can rise as vitamin D supply becomes inadequate. However, studies have reported different apparent PTH breakpoints, and some populations show a continuous relationship rather than one universal plateau. PTH also varies with renal function, age, calcium intake, body composition and other factors.
Calcium absorption provides another example. In a randomised trial of postmenopausal women with low 25(OH)D, vitamin D supplementation raised serum concentrations substantially, but the change in calcium absorption across a broad 25(OH)D range was modest and did not reveal a clear threshold supporting one higher universal target.
These findings help explain why Why Vitamin D Insufficiency Is Not a Universal Cut-Off treats intermediate vitamin D status as continuous and context-dependent rather than as one globally fixed band.
A higher target needs separate evidence
A proposed functional target makes a stronger claim than a deficiency threshold. It implies that maintaining a higher concentration improves an identified endpoint. That conclusion must be demonstrated for the relevant population and outcome; it cannot simply be inferred from the fact that severe deficiency is harmful.
The Endocrine Society’s 2024 guideline illustrates this evidential distinction. After reviewing randomised trials in generally healthy populations, its panel concluded that available evidence did not permit identification of outcome-specific 25(OH)D thresholds that reliably predicted benefit from supplementation. The Society therefore stopped endorsing its previous universal 30 ng/mL sufficiency definition for generally healthy people.
This does not erase deficiency or prove that higher concentrations are never appropriate. It means that the evidence for recognising low vitamin D status is different from the evidence required to define a universal higher target.
Interpret the number according to the question
A concentration may represent a population adequacy estimate, a diagnostic threshold, a laboratory classification, a treatment trigger or a proposed optimisation target. These functions should not be collapsed into one meaning. Vitamin D Sufficiency Explained and Population Reference Ranges Explained show why apparently similar numerical ranges can serve different interpretive purposes.
The central distinction is therefore simple: a deficiency threshold marks a boundary at which concern becomes justified for a defined purpose. A functional target requires additional evidence that aiming higher produces additional meaningful benefit.
Scientific sources
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.
Gallagher JC, Yalamanchili V, Smith LM. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550-3556. PMID: 22855333. PMCID: PMC3462946. DOI: 10.1210/jc.2012-2020.
McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.
Related reading
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis
The Amgen cinacalcet pediatric clinical development program consisted of two Phase 3 randomized studies, one Phase 3 single arm extension study, one open-label Phase 2 study, and two open-label Phase 1 studies.
Original paper ↗Read more →Physiological Distinction Between Vitamin D Deficiency Thresholds and Functional Target Ranges: Full Study
Examine the physiological distinction between vitamin D deficiency thresholds and functional target ranges, including calcium regulation, PTH evidence and the limits of fixed cut-offs.
Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
By recruiting reference population, we aimed to (1): estimate the 25(OH)D threshold that maximally inhibits the PTH, which can be defined as the cutoff value for vitamin D sufficiency; (2) establish the PTH reference interval (RI) in population with sufficient vitamin D.
Original paper ↗Read more →Targets for parathyroid hormone in secondary hyperparathyroidism: is a “one-size-fits-all” approach appropriate? A prospective incident cohort study
Recommendations for secondary hyperparathyroidism (SHPT) consider that a “one-size-fits-all” target enables efficacy of care.
Original paper ↗Read more →Tubular functional capacity and maladaptive parathyroid hormone response in early-stage chronic kidney disease
TFC was evaluated by measuring effective renal plasma flow (mERPF, mL/min/1.73m2) using (131I) Hippurate (131I-H) clearance, while GFR was measured using (99m) Tc-DTPA (mGFR, mL/min/1.73m2).
Original paper ↗Read more →Higher Proportion of Non-1-84 PTH Fragments in Peritoneal Dialysis Patients Compared to Hemodialysis Patients Using Solutions Containing 1.75 mmol/l Calcium
The prevalence of low: turnover bone disease (LTBD) in peritoneal dialysis (PD) patients is higher than in hemodialysis (HD) patients.
Original paper ↗Read more →Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Parathyroid hormone in Sri Lankan pregnant women: Vitamin D and other determinants
We aimed to describe the serum parathyroid hormone (PTH) and its determinants in Sri Lankan pregnant women in a community setting.
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →Prognosis comparison in chronic kidney disease stages 4 to 5 patients with low parathyroid hormone level due to different causes
This study examines prognostic implications of PTH reduction from different etiologies.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →The relationship between serum 25-hydroxyvitamin D and parathyroid hormone concentration in assessing vitamin D deficiency in pet rabbits
Thus, this study aimed to identify the breakpoint in the 25-hydroxyvitamin D concentration indicating a significant change in the parathyroid hormone concentration in 139 pet rabbits.
Original paper ↗Read more →The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study
Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database.
Original paper ↗Read more →Why a Vitamin D Deficiency Threshold Is Not the Same as a Functional Target
Understand why a vitamin D deficiency threshold and a functional target answer different questions and why treating them as interchangeable creates false precision.
Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Why Vitamin D Insufficiency Is Not a Universal Cut-Off
Learn why vitamin D insufficiency has no universal numerical cut-off and how physiology, guideline purpose, population thresholds and measurement variability affect interpretation.Page type: Context.
Read more →Context-Dependent Association Between Serum 25-Hydroxyvitamin D and Romosozumab Bone Mineral Density Response: A Stratified Analysis by Renal Function Category and Prior Treatment History in a Real-World Japanese Cohort
This study investigated whether the renal function category and prior treatment history modified the association between baseline 25OHD and romosozumab BMD response.
Original paper ↗Read more →Serum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn Study
Therefore, we investigated whether lower 25-hydroxyvitamin D (25(OH)D) and higher PTH are cross sectionally and after 8 years of follow-up associated with higher B-type natriuretic peptide (BNP) levels in older men and women.
Original paper ↗Read more →Original sources
The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know
Published in Journal of Clinical Endocrinology & Metabolism (2011).
Publication details
Ross AC, Manson JE, Abrams SA, et al. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know. Journal of Clinical Endocrinology & Metabolism. 2011;96(1):53-58. PMID: 21118827. PMCID: PMC3046611. DOI: 10.1210/jc.2010-2704.
The Effect of Vitamin D on Calcium Absorption in Older Women
Published in Journal of Clinical Endocrinology & Metabolism (2012).
Publication details
Gallagher JC, Yalamanchili V, Smith LM. The Effect of Vitamin D on Calcium Absorption in Older Women. Journal of Clinical Endocrinology & Metabolism. 2012;97(10):3550-3556. PMID: 22855333. PMCID: PMC3462946. DOI: 10.1210/jc.2012-2020.
Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication
Published in Journal of Clinical Endocrinology & Metabolism (2024).
Publication details
McCartney CR, McDonnell ME, Corrigan MD, Lash RW. Vitamin D Insufficiency and Epistemic Humility: An Endocrine Society Guideline Communication. Journal of Clinical Endocrinology & Metabolism. 2024;109(8):1948-1954. DOI: 10.1210/clinem/dgae322.